Am 29. Januar 2016 wurde das Ablaufdatum der Genehmigung von Flocoumafen, Brodifacoum und Warfarin zur Verwendung in Biozidprodukten der Produktart 14 mittels Durchführungsbeschluss (EU) 2016/135 auf den 30. Juni 2018 verschoben.
MENUMENU
- THE SEFIRO GROUP
- THE COMPANY
Everything that we do relates to the issue of quality. An introduction to the SEFIRO Group.
- JOBS
Discover the current vacancies at the SEFIRO GROUP and its companies. Apply straightaway!
- COMPANIES
- NEWS
- NEWS
-
We will gladly inform you about the latest research results, articles about quality management and new requirements in statutory regulations.
-
Recent Posts
- TO THE ARCHIVE
You will find articles that appeared before 2021 here in the archive.
- CONTACT